Middle Eastern Penny Stocks With At Least US$10M Market Cap

Most Gulf markets have recently experienced a downturn, influenced by lackluster corporate earnings and ongoing global economic discussions, such as U.S.-China trade talks and Federal Reserve policy decisions. In this context, penny stocks—though an older term—remain relevant for investors seeking potential growth opportunities at lower price points. These stocks often represent smaller or newer companies that can offer value and growth potential when supported by strong financials.

Top 10 Penny Stocks In The Middle East

Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Duran Dogan Basim ve Ambalaj Sanayi (IBSE:DURDO)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Duran Dogan Basim ve Ambalaj Sanayi A.S., along with its subsidiaries, offers packaging products across Turkey and various international markets including Europe, the United States, the Middle East, Africa, and the Asia Pacific, with a market cap of TRY1.62 billion.

Operations: The company generates revenue primarily from its Packaging & Containers segment, amounting to TRY2 billion.

Market Cap: TRY1.62B

Duran Dogan Basim ve Ambalaj Sanayi A.S. operates with a market cap of TRY1.62 billion and generated TRY2 billion in revenue from its Packaging & Containers segment last year, although it faced a net loss of TRY159.2 million. The company has managed to reduce its debt-to-equity ratio significantly over five years, now at 37.6%, and maintains satisfactory net debt levels (35.1%). Despite high share price volatility and negative return on equity, the firm covers both short- and long-term liabilities with assets exceeding liabilities by a comfortable margin, indicating financial stability amidst current unprofitability challenges.

• Click here to discover the nuances of Duran Dogan Basim ve Ambalaj Sanayi with our detailed analytical financial health report.
• Evaluate Duran Dogan Basim ve Ambalaj Sanayi's historical performance by accessing our past performance report.

Matricelf (TASE:MTLF)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Matricelf Ltd is a biotechnology company focused on developing a platform for autologous tissue engineering to address various medical conditions, with a market cap of ₪49.73 million.

Operations: Currently, Matricelf Ltd does not report any revenue segments.

Market Cap: ₪49.73M

Matricelf Ltd, with a market cap of ₪49.73 million, is a pre-revenue biotechnology company focusing on innovative regenerative therapies. Despite being unprofitable and having less than a year of cash runway, Matricelf remains debt-free and covers its liabilities comfortably with short-term assets of ₪12.6 million. Recent collaboration with Cellino aims to advance personalized spinal cord injury treatments using cutting-edge biomanufacturing technology. This partnership could accelerate clinical applications in regenerative medicine as Matricelf plans to file an IND application next year for its iPSC-derived therapy, potentially addressing significant unmet medical needs globally.

• Dive into the specifics of Matricelf here with our thorough balance sheet health report.
• Understand Matricelf's track record by examining our performance history report.

Ratio Petroleum Energy - Limited Partnership (TASE:RTPT)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Ratio Petroleum Energy - Limited Partnership focuses on the exploration, development, and production of oil and gas, with a market cap of ₪64.07 million.

Operations: Ratio Petroleum Energy - Limited Partnership has not reported any specific revenue segments.

Market Cap: ₪64.07M

Ratio Petroleum Energy - Limited Partnership, with a market cap of ₪64.07 million, is a pre-revenue oil and gas exploration company facing financial challenges. Despite being debt-free and having short-term assets of $5.1M that exceed liabilities, it remains unprofitable with a net loss of US$4.18 million for 2024. The company's cash runway is less than one year if current free cash flow growth continues, highlighting potential liquidity concerns. Its share price has been highly volatile over the past three months, and while shareholder dilution hasn't occurred recently, the lack of revenue streams poses significant risks to investors.

• Click to explore a detailed breakdown of our findings in Ratio Petroleum Energy - Limited Partnership's financial health report.
• Examine Ratio Petroleum Energy - Limited Partnership's past performance report to understand how it has performed in prior years.

Key Takeaways

• Jump into our full catalog of 94 Middle Eastern Penny Stocks here.
• Contemplating Other Strategies? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com